Hello and Welcome to My Personal Website
I am a TRIUMPH and NCI F32 Postdoctoral Fellow at MD Anderson Cancer Center. I received my MS and PhD in Cellular and Molecular Pharmacology and Physiology (CMPP) at University of Rochester Medical Center (URMC) in Rochester, NY.
My PhD research project in leukemia was focused on investigating new molecular strategies that improve patients’ survival rates, and reduce lethality, especially 3q26 rearrangements leukemia. During my PhD, I successfully received a Ruth L. Kirschstein Predoctoral Individual National Research Service Award (NRSA) (F31HL143994) from The National Institutes of Health (NIH) / National Heart, Lung, and Blood Institute (NHLBI) to pursue my studies (link), and published my research entitled "EVI1 overexpression reprograms hematopoiesis via upregulation of Spi1 transcription" in Nature Communications (link). During my ongoing postdoctoral research at MD Anderson, I have received a Ruth L. Kirschstein Postdoctoral Individual National Research Service Award (NRSA) (F32CA271697) from the NIH/National Cancer Institute (NCI) to investigate my project entitled: "Targeting Quiescence Pathways to Overcome Chemoresistance in EVI1-Overexpressing Leukemia" (link).